Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial.

Saved in:
Bibliographic Details
Title: Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial.
Authors: de Almeida Baptista, Marcella Vassão1 (AUTHOR), da Silva, Laís Teodoro2 (AUTHOR), Samer, Sadia3 (AUTHOR), Oshiro, Telma Miyuki2 (AUTHOR), Shytaj, Iart Luca1 (AUTHOR), Giron, Leila B.4 (AUTHOR), Pena, Nathalia Mantovani1 (AUTHOR), Cruz, Nicolly1 (AUTHOR), Gosuen, Gisele Cristina1 (AUTHOR), Ferreira, Paulo Roberto Abrão1 (AUTHOR), Cunha-Neto, Edécio2 (AUTHOR), Galinskas, Juliana1 (AUTHOR), Dias, Danilo1 (AUTHOR), Sucupira, Maria Cecilia Araripe1 (AUTHOR), de Almeida-Neto, Cesar5,6 (AUTHOR), Salomão, Reinaldo1 (AUTHOR), da Silva Duarte, Alberto José2 (AUTHOR), Janini, Luís Mário1 (AUTHOR), Hunter, James R.1 (AUTHOR), Savarino, Andrea7 (AUTHOR)
Source: AIDS Research & Therapy. 1/12/2022, Vol. 19 Issue 1, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17426405
DOI:10.1186/s12981-021-00426-z